EDRS
VRTX icon

Edmond de Rothschild (Suisse)’s Vertex Pharmaceuticals VRTX Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.24M Buy
25,650
+800
+3% +$75.6K 0.69% 30
2016
Q2 		$2.14M Buy
+24,850
New +$2.15M 0.71% 36

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s VRTX Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) increased its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q3 2016, buying an estimated $75.6K and bringing the position to 25,650 shares worth $2.24M. The position accounts for 0.69% of the portfolio, ranked #30.

Edmond de Rothschild (Suisse) first reported a position in VRTX in Q2 2016 and has held it in 2 quarters since. 490 funds tracked by Wall St. Rank hold VRTX as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 25,650 shares of Vertex Pharmaceuticals worth $2.24M as of Q3 2016.
  • Edmond de Rothschild (Suisse) bought 800 Vertex Pharmaceuticals shares in Q3 2016, an estimated $75.6K.
  • Vertex Pharmaceuticals made up 0.69% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #30 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Vertex Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 490 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.